PetMed Express, Inc. (PETS)

PetMed Express experienced several stock events in the past six months. Delayed filings and an internal investigation led to a stock price drop in November 2025. The company received unsolicited acquisition proposals from SilverCape Investments Limited and Cardone Ventures, which generally led to increases in the stock price. PetMeds extended its existing shareholder rights plan by one year. The company's Audit Committee appointed Baker Tilly US, LLP as the new independent registered public accounting firm.

Demand for pet medications and services exhibits some seasonality. Veterinary practices experience seasonal revenue, with the fourth quarter typically being the slowest. There is also an observed seasonality in specific pet prescriptions and parasiticide products.

PetMed Express, Inc., also known as PetMeds and the parent company of PetCareRx, is a direct-to-consumer pet pharmacy in the United States, operating in the Healthcare sector. The company markets prescription medications, non-prescription medications and supplies, and other pet supplies for dogs, cats, and horses. PetMed Express also offers private label and holistic wellness services, and has membership programs like PetPlus.

PetMed Express, Inc. operates as a national online pet pharmacy across the United States and is licensed in all 50 states. All of its sales are domestic and direct to consumers. The company is headquartered in Delray Beach, Florida.

PetMed Express's brand reputation has been primarily affected by financial reporting issues and related investigations. Delays in filing earnings releases and annual reports led to a class-action investigation and notices from Nasdaq regarding non-compliance with listing rules.

PetMed Express, Inc. has a mixed ownership structure, with significant holdings by institutional investors, individual insiders, and retail investors. Major institutional shareholders include Renaissance Technologies Llc, Vanguard Group Inc and Hotchkis & Wiley Capital Management Llc. Individual insiders, including executives and board members, also hold shares in the company.